• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Merlin Biotech, Inc.

Tuesday, June 04, 2024
Start-Up Stadium Session
Oncology
Merlin has a pre-clinical mRNA-delivered immune activator with strong IP with in-vivo and human epi survival data in both pediatric ($100M PRV) and $2B adult markets.
Company Website: http://www.merlinbiotech.com

Company HQ City

Doylestown

Company HQ State

PA

Company HQ Country

United States

CEO/Top Company Official

Randall N. Hyer
Speakers
Randall Hyer, MD
CEO
Merlin Biotech, Inc.
Back to Session List

white squarewhite

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS